DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $190,046 | -27.6% | 766,004 | -30.0% | 0.23% | -27.9% |
Q2 2023 | $262,622 | -20.4% | 1,094,258 | -16.4% | 0.32% | -25.3% |
Q1 2023 | $330,076 | +26.5% | 1,309,618 | +33.2% | 0.43% | +17.0% |
Q4 2022 | $260,887 | -99.7% | 982,922 | +148.9% | 0.36% | +143.3% |
Q3 2022 | $102,001,000 | -52.2% | 394,909 | -53.1% | 0.15% | -50.3% |
Q2 2022 | $213,478,000 | -35.8% | 842,054 | -25.7% | 0.30% | -27.2% |
Q1 2022 | $332,537,000 | -10.5% | 1,133,661 | +0.4% | 0.42% | -8.6% |
Q4 2021 | $371,414,000 | +29.3% | 1,128,884 | +19.6% | 0.45% | +26.1% |
Q3 2021 | $287,355,000 | +46.3% | 943,882 | +29.0% | 0.36% | +49.4% |
Q2 2021 | $196,355,000 | +207.6% | 731,686 | +158.0% | 0.24% | +183.5% |
Q1 2021 | $63,830,000 | +132.3% | 283,588 | +129.2% | 0.08% | +117.9% |
Q4 2020 | $27,480,000 | +189.4% | 123,708 | +180.5% | 0.04% | +160.0% |
Q3 2020 | $9,496,000 | +490.2% | 44,100 | +384.6% | 0.02% | +400.0% |
Q2 2020 | $1,609,000 | -87.5% | 9,100 | -90.2% | 0.00% | -91.7% |
Q1 2020 | $12,858,000 | +892.1% | 92,897 | +1000.5% | 0.04% | +1100.0% |
Q4 2019 | $1,296,000 | -97.4% | 8,441 | -98.1% | 0.00% | -97.3% |
Q3 2018 | $49,576,000 | +42.7% | 456,253 | +29.6% | 0.11% | +31.8% |
Q2 2018 | $34,745,000 | +12580.7% | 352,092 | +12474.7% | 0.08% | +8400.0% |
Q1 2018 | $274,000 | -55.7% | 2,800 | -61.1% | 0.00% | -50.0% |
Q3 2017 | $618,000 | -99.5% | 7,200 | -99.5% | 0.00% | -99.5% |
Q2 2017 | $125,395,000 | +16185.1% | 1,485,901 | +16410.0% | 0.38% | +12566.7% |
Q1 2017 | $770,000 | – | 9,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
Third Point | 2,450,000 | $607,845,000 | 9.22% |
Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |